Abstract
To determine, using a specific small-molecule inhibitor of protease-activated receptor 1 (PAR1) signaling, whether the beneficial effect of thrombin inhibition on radiation enteropathy development is due to inhibition of blood clotting or to cellular (PAR1-mediated) thrombin effects. Rats underwent fractionated X-irradiation (5 Gy×9) of a 4-cm small-bowel segment. Early radiation toxicity was evaluated in rats receiving PAR1 inhibitor (SCH602539, 0, 10, or 15 mg/kg/d) from 1 day before to 2 weeks after the end of irradiation. The effect of PAR1 inhibition on development of chronic intestinal radiation fibrosis was evaluated in animals receiving SCH602539 (0, 15, or 30 mg/kg/d) until 2 weeks after irradiation, or continuously until termination of the experiment 26 weeks after irradiation. Blockade of PAR1 ameliorated early intestinal toxicity, with reduced overall intestinal radiation injury (P=.002), number of myeloperoxidase-positive (P=.03) and proliferating cell nuclear antigen-positive (P=.04) cells, and collagen III accumulation (P=.005). In contrast, there was no difference in delayed radiation enteropathy in either the 2- or 26-week administration groups. Pharmacological blockade of PAR1 seems to reduce early radiation m...Continue Reading
References
Nov 1, 1989·Journal of Ethnopharmacology·A O Oyekan, J P Okafor
Jun 1, 1988·International Journal of Radiation Oncology, Biology, Physics·M Hauer-JensenJ W Osborne
Jun 1, 1986·Journal of Microscopy·A J BaddeleyL M Cruz-Orive
Jan 1, 1996·Acta Oncologica·C W LangbergM Hauer-Jensen
Jan 1, 1997·World Journal of Urology·G RavivE Wespes
Jul 1, 1997·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K K RichterM Hauer-Jensen
Dec 29, 2000·Annals of Hematology·J RuefM S Runge
Jul 14, 2001·Science·F ParisR Kolesnick
Jun 8, 2002·Science·Matthias RiewaldWolfram Ruf
Jun 12, 2002·The American Journal of Pathology·Junru WangMartin Hauer-Jensen
Mar 4, 2003·Nature Medicine·Wolfram Ruf
Sep 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·Alex C ChinAndre G Buret
Nov 17, 2004·The Journal of Clinical Investigation·Nathalie VergnolleStefano Fiorucci
Nov 20, 2004·Journal of Thrombosis and Haemostasis : JTH·J WangM Hauer-Jensen
Aug 24, 2005·Inflammatory Bowel Diseases·Nicolas CenacNathalie Vergnolle
Aug 22, 2007·The British Journal of Radiology·J Wang, M Hauer-Jensen
Nov 28, 2009·Current Medicinal Chemistry·M Teresa García-LópezRosario Herranz
Jul 27, 2010·European Journal of Pharmacology·Florence Nadal-WollboldBruno Le Grand
Citations
Jan 27, 2015·Chemistry & Biology·Renukadevi PatilGábor J Tigyi
Nov 18, 2015·Cancer Metastasis Reviews·Marek Z WojtukiewiczKenneth V Honn
Aug 2, 2018·Cancers·Annalisa BrunoPaola Patrignani
Jan 13, 2017·Journal of Thrombosis and Haemostasis : JTH·C LinC A Spek
Nov 13, 2020·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Guanqun ChaoShuo Zhang